Merck & Company, Inc. vs Revolution Medicines, Inc. — Stock Comparison
Merck & Company, Inc. (MRK) and Revolution Medicines, Inc. (RVMD) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Merck & Company, Inc. clearly outscores Revolution Medicines, Inc. on Q·Score (7 vs 5 out of 10), led by Quality (7.7 vs 2) and Valuation (6.7 vs 4.2). Revolution Medicines, Inc. scores higher on Sentiment, reflecting stronger analyst and market sentiment. Analyst price targets imply similar upside for both: +13.9% for MRK and +14.9% for RVMD.
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
High-quality business with 19% return on equity and 14% profit margins.
95% of 21 covering analysts have a positive rating.
⚠ low return on equity (-77%).
Analyst Consensus
Fundamentals
Frequently Asked Questions
MRK vs RVMD: which stock scores better overall?
Based on Q·Score, Merck & Company, Inc. (MRK) scores 7/10 versus Revolution Medicines, Inc. (RVMD) at 5/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: MRK or RVMD?
Merck & Company, Inc. (MRK) scores higher on Growth (6.2/10 vs 3.8/10). Merck & Company, Inc. reports revenue growth (4.9% YoY) while Revolution Medicines, Inc. reports. Growth scores reflect revenue and earnings momentum relative to sector peers.
Is MRK or RVMD more attractively valued?
Merck & Company, Inc. (MRK) scores higher on Valuation (6.7/10 vs 4.2/10). Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about MRK vs RVMD?
There are 27 analysts covering MRK with a consensus price target of $129.74, and 21 analysts covering RVMD with a consensus target of $187.29. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: MRK or RVMD?
Merck & Company, Inc. (MRK) scores higher on Quality (7.7/10 vs 2/10). Net profit margin: MRK at 13.6%, RVMD at 0.0%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: MRK or RVMD?
Revolution Medicines, Inc. (RVMD) scores higher on Financial Health (7.7/10 vs 7/10). Market beta: MRK at 0.22, RVMD at 1.41. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of MRK and RVMD?
Merck & Company, Inc. (MRK) has a market capitalisation of $281.2B, while Revolution Medicines, Inc. (RVMD) has a market cap of $34.7B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do MRK or RVMD pay dividends?
MRK pays a dividend yield of 2.95%, while RVMD does not currently pay a dividend. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →